Results: Several studies show that GLP-1RAs, particularly liraglutide and semaglutide, improve PsO severity, metabolic parameters, and inflammatory markers
What dose produces the best outcomes
Collectively, these findings led Lonza to use exercise as a model to induce an inflammatory state and to upregulate ACE2 levels similar to those seen in chronic diseases
Side effects are usually mild and can be managed at home by eating small, plain meals, staying hydrated, and taking over-the-counter painkillers if needed
These innovations hold promise to elevate therapeutic efficacy and patient-specific outcomes in gout management
Individuals With Type 1 Diabetes While semaglutide can be highly effective for patients with type 2 diabetes, it is not designed for type 1 diabetes